Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System
The implementation of a complex risk-oriented approach at all stages of drug development, including the preclinical research stage, is essential for ensuring drug safety, quality and effi cacy. The aim of the study was to justify the benefits of introducing risk management into the integrated quality...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2020-03-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/159 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849252364492472320 |
|---|---|
| author | M. A. Zaytseva M. B. Ivanov A. B. Verveda L. V. Lyanginen |
| author_facet | M. A. Zaytseva M. B. Ivanov A. B. Verveda L. V. Lyanginen |
| author_sort | M. A. Zaytseva |
| collection | DOAJ |
| description | The implementation of a complex risk-oriented approach at all stages of drug development, including the preclinical research stage, is essential for ensuring drug safety, quality and effi cacy. The aim of the study was to justify the benefits of introducing risk management into the integrated quality management system at the preclinical trial stage. The optimal approach to implementing risk management system at the preclinical stage is an overall process approach based on the international standard ISO 31000:2009 Risk management—Principles and guidelines. This approach as applied to a preclinical research centre includes a three-tier risk management system at the level of operational process subsystems, the level of the testing centre’s departments, and the level of an individual preclinical study. The common components of the subsystems may include concepts, organisational structure, information exchange system, documentation structure, etc. The process of risk management as applied to the subsystems includes risk identification, analysis, assessment, and response to the risk. The response to the risk is an iterative process that includes selection of response options, response planning, and implementation of response activities from control procedures to corrective and preventive actions. The integration of the preclinical risk management system into the organisation’s overall management system, which includes the occupational health and safety management system and the quality management system, will enhance the capabilities of the individual systems to achieve a high quality level of research, preserve the staff ’s professional health, make informed management decisions within the organisation, increase preparedness for external audits, and gain competitive advantages. |
| format | Article |
| id | doaj-art-2c457624d83a4bb9964134750bd06fb9 |
| institution | Kabale University |
| issn | 2312-7821 2619-1164 |
| language | Russian |
| publishDate | 2020-03-01 |
| publisher | Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
| record_format | Article |
| series | Безопасность и риск фармакотерапии |
| spelling | doaj-art-2c457624d83a4bb9964134750bd06fb92025-08-20T03:56:40ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642020-03-0181364210.30895/2312-7821-2020-8-1-36-42156Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management SystemM. A. Zaytseva0M. B. Ivanov1A. B. Verveda2L. V. Lyanginen3Institute of Toxicology of Russian Federal Medical Biological AgencyInstitute of Toxicology of Russian Federal Medical Biological AgencyInstitute of Toxicology of Russian Federal Medical Biological AgencyInstitute of Toxicology of Russian Federal Medical Biological AgencyThe implementation of a complex risk-oriented approach at all stages of drug development, including the preclinical research stage, is essential for ensuring drug safety, quality and effi cacy. The aim of the study was to justify the benefits of introducing risk management into the integrated quality management system at the preclinical trial stage. The optimal approach to implementing risk management system at the preclinical stage is an overall process approach based on the international standard ISO 31000:2009 Risk management—Principles and guidelines. This approach as applied to a preclinical research centre includes a three-tier risk management system at the level of operational process subsystems, the level of the testing centre’s departments, and the level of an individual preclinical study. The common components of the subsystems may include concepts, organisational structure, information exchange system, documentation structure, etc. The process of risk management as applied to the subsystems includes risk identification, analysis, assessment, and response to the risk. The response to the risk is an iterative process that includes selection of response options, response planning, and implementation of response activities from control procedures to corrective and preventive actions. The integration of the preclinical risk management system into the organisation’s overall management system, which includes the occupational health and safety management system and the quality management system, will enhance the capabilities of the individual systems to achieve a high quality level of research, preserve the staff ’s professional health, make informed management decisions within the organisation, increase preparedness for external audits, and gain competitive advantages.https://www.risksafety.ru/jour/article/view/159preclinical trialsgood laboratory practicerisk managementquality management systemsafety management systemregulatory documentation |
| spellingShingle | M. A. Zaytseva M. B. Ivanov A. B. Verveda L. V. Lyanginen Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System Безопасность и риск фармакотерапии preclinical trials good laboratory practice risk management quality management system safety management system regulatory documentation |
| title | Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System |
| title_full | Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System |
| title_fullStr | Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System |
| title_full_unstemmed | Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System |
| title_short | Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System |
| title_sort | risk management in preclinical trials as part of an overall integrated quality management system |
| topic | preclinical trials good laboratory practice risk management quality management system safety management system regulatory documentation |
| url | https://www.risksafety.ru/jour/article/view/159 |
| work_keys_str_mv | AT mazaytseva riskmanagementinpreclinicaltrialsaspartofanoverallintegratedqualitymanagementsystem AT mbivanov riskmanagementinpreclinicaltrialsaspartofanoverallintegratedqualitymanagementsystem AT abverveda riskmanagementinpreclinicaltrialsaspartofanoverallintegratedqualitymanagementsystem AT lvlyanginen riskmanagementinpreclinicaltrialsaspartofanoverallintegratedqualitymanagementsystem |